Noetik, a biotechnology company focused on artificial intelligence, announced that it has successfully completed a $40 million Series A funding round. The round was led by Polaris Partners, with participation from new investors including Khosla Ventures, Wittington Ventures, Breakout Ventures, as well as existing investors DCVC, Zetta Venture Partners, and Catalio Capital Management.

Researchers evaluated the reliability of cancer treatment recommendations provided by large language model chatbots and found that 33.33% of the suggestions were not fully aligned with established guidelines. The chatbot recommendations did not fully align with NCCN guidelines, and experts also failed to detect these errors, highlighting that LLM chatbots perform below average in providing reliable and accurate cancer treatment advice. Given the widespread use of AI, healthcare providers need to adequately educate patients about the potential risks of misinformation that this technology may provide.